Vijaya Diagnostic Centre declared their Q3 FY24 results on 05 Feb, 2024. The topline increased by 17.3% & the profit increased by 57.96% YoY. As compared to the previous quarter, the revenue declined by 4.44% and the profit decreased by 22.43%.
The Selling, general & administrative expenses rose by 5.54% q-o-q & increased by 16.7% Y-o-Y.
The operating income was down by 18.23% q-o-q & increased by 48.81% Y-o-Y.
The EPS is ₹2.67 for Q3 FY24 which increased by 66.84% Y-o-Y.
Vijaya Diagnostic Centre has delivered -4.42% return in the last 1 week, 34.13% return in the last 6 months, and -8.22% YTD return.
Currently, Vijaya Diagnostic Centre has a market cap of ₹6344.67 Cr and a 52wk high/low of ₹698.95 & ₹349.25 respectively.
As of 07 Feb, 2024, out of 3 analysts covering the company, 1 analyst has given a Sell rating, 1 analyst has given a Buy rating, and 1 analyst has given a Strong Buy rating.
The consensus recommendation as of 07 Feb, 2024, was to Buy.
Vijaya Diagnostic Centre Financials
Period | Q3 FY24 | Q2 FY24 | Q-o-Q Growth | Q3 FY23 | Y-o-Y Growth |
---|---|---|---|---|---|
Total Revenue | 132.69 | 138.86 | -4.44% | 113.12 | +17.3% |
Selling/ General/ Admin Expenses Total | 23.03 | 21.82 | +5.54% | 19.73 | +16.7% |
Depreciation/ Amortization | 14.54 | 13.69 | +6.23% | 20.28 | -28.32% |
Total Operating Expense | 96.98 | 95.18 | +1.89% | 89.12 | +8.82% |
Operating Income | 35.71 | 43.68 | -18.23% | 24 | +48.81% |
Net Income Before Taxes | 34.76 | 44.58 | -22.01% | 22.02 | +57.88% |
Net Income | 25.85 | 33.32 | -22.43% | 16.36 | +57.96% |
Diluted Normalized EPS | 2.67 | 3.25 | -17.86% | 1.6 | +66.84% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
MoreLess